15-72474873-T-TGGC
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_005744.5(ARIH1):c.255_257dupCGG(p.Gly86dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0682 in 1,412,176 control chromosomes in the GnomAD database, including 2,491 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.057 ( 340 hom., cov: 32)
Exomes 𝑓: 0.070 ( 2151 hom. )
Consequence
ARIH1
NM_005744.5 disruptive_inframe_insertion
NM_005744.5 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.74
Genes affected
ARIH1 (HGNC:689): (ariadne RBR E3 ubiquitin protein ligase 1) Enables enzyme binding activity; ubiquitin-protein transferase activity; and zinc ion binding activity. Involved in protein ubiquitination. Located in Lewy body; cytoplasm; and nuclear body. Colocalizes with cullin-RING ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 15-72474873-T-TGGC is Benign according to our data. Variant chr15-72474873-T-TGGC is described in ClinVar as [Benign]. Clinvar id is 402394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0788 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARIH1 | NM_005744.5 | c.255_257dupCGG | p.Gly86dup | disruptive_inframe_insertion | 1/14 | ENST00000379887.9 | NP_005735.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARIH1 | ENST00000379887.9 | c.255_257dupCGG | p.Gly86dup | disruptive_inframe_insertion | 1/14 | 1 | NM_005744.5 | ENSP00000369217.4 | ||
ARIH1 | ENST00000564062.1 | c.249_251dupCGG | p.Gly84dup | disruptive_inframe_insertion | 1/4 | 3 | ENSP00000454774.1 | |||
TMEM202-AS1 | ENST00000565181.1 | n.293_295dupGCC | non_coding_transcript_exon_variant | 1/1 | 6 | |||||
ARIH1 | ENST00000570085.5 | n.255_257dupCGG | non_coding_transcript_exon_variant | 1/5 | 3 | ENSP00000456746.1 |
Frequencies
GnomAD3 genomes AF: 0.0569 AC: 8521AN: 149668Hom.: 338 Cov.: 32
GnomAD3 genomes
AF:
AC:
8521
AN:
149668
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0577 AC: 3555AN: 61656Hom.: 94 AF XY: 0.0549 AC XY: 1895AN XY: 34494
GnomAD3 exomes
AF:
AC:
3555
AN:
61656
Hom.:
AF XY:
AC XY:
1895
AN XY:
34494
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0696 AC: 87828AN: 1262402Hom.: 2151 Cov.: 30 AF XY: 0.0681 AC XY: 42151AN XY: 619134
GnomAD4 exome
AF:
AC:
87828
AN:
1262402
Hom.:
Cov.:
30
AF XY:
AC XY:
42151
AN XY:
619134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0569 AC: 8528AN: 149774Hom.: 340 Cov.: 32 AF XY: 0.0586 AC XY: 4286AN XY: 73138
GnomAD4 genome
AF:
AC:
8528
AN:
149774
Hom.:
Cov.:
32
AF XY:
AC XY:
4286
AN XY:
73138
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
ARIH1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at